|
|
|
|
LEADER |
03220nam a22004335i 4500 |
001 |
978-1-4020-5133-3 |
005 |
20191021222902.0 |
007 |
cr nn 008mamaa |
008 |
100904s2006 ne | s |||| 0|eng d |
020 |
|
|
|a 9781402051333
|
024 |
7 |
|
|a 10.1007/978-1-4020-5133-3
|2 doi
|
040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
245 |
1 |
0 |
|a New Trends in Cancer for the 21st Century
|c edited by Antonio Llombart-Bosch, José A. López-Guerrero, Vicente Felipo.
|
250 |
|
|
|a 2nd ed. 2006.
|
260 |
# |
# |
|a Dordrecht :
|b Springer Netherlands :
|b Imprint: Springer,
|c 2006.
|
300 |
|
|
|a XXIV, 396 p.
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Advances in Experimental Medicine and Biology,
|v 587
|
505 |
0 |
|
|a Prognostic and Therapeutic Targets in the Ewing's Family of Tumors (PROTHETS) -- Targeted Therapies in Ewing's Sarcoma -- The CCN3 Protein and Cancer -- Ews-Fli1 in Ewing's Sarcoma: Real Targets and Collateral Damage -- Molecular Karyotyping in Sarcoma Diagnostics and Research -- TuBaFrost: European Virtual Tumor Tissue Banking -- Virtual Microscopy in Virtual Tumor Banking -- Harmonizing Cancer Control in Europe -- The Diagnosis of Cancer: “From H&E to Molecular Diagnosis and Back“ -- From Morphological to Molecular Diagnosis of Soft Tissue Tumors -- Prediction of Response to Neoadjuvant Chemotherapy in Carcinomas of the Upper Gastrointestinal Tract -- Integrating the Diagnosis of Childhood Malignancies -- Preclinical Models for Cell Cycle-Targeted Therapies -- WWOX, a Chromosomal Fragile Site Gene and its Role in Cancer -- From Genome to Proteome in Tumor Profiling: Molecular Events in Colorectal Cancer Genesis -- Effect of Hypoxia on the Tumor Phenotype: The Neuroblastoma and Breast Cancer Models -- Methylation Patterns and Chemosensitivity in NSCLC -- Pharmacogenomics and Colorectal Cancer -- Development of Pharmacogenomic Predictors for Preoperative Chemotherapy of Breast Cancer -- Vascular Endothelial Growth Factor Inhibitors in Colon Cancer -- Molecular Imaging of Cancer Using PET and SPECT -- MRS as Endogenous Molecular Imaging for Brain and Prostate Tumors: FP6 Project “eTUMOR“ -- From Linac to Tomotherapy: New Possibilities for Cure? -- Targeting mTOR for Cancer Treatment -- Dual/Pan-Her Tyrosine Kinase Inhibitors: Focus in Breast Cancer -- AntiTumor-Associated Antigens IGGS: Dual Positive and Negative Potential Effects for Cancer Therapy -- Synergistic Molecular Mechanisms in Hormone-Sensitive Breast Cancer.
|
650 |
|
0 |
|a Oncology .
|
650 |
|
0 |
|a Medicine.
|
650 |
|
0 |
|a Cancer research.
|
650 |
|
0 |
|a Pathology.
|
650 |
|
0 |
|a Molecular biology.
|
650 |
|
0 |
|a Biotechnology.
|
650 |
1 |
4 |
|a Oncology.
|
650 |
2 |
4 |
|a Biomedicine, general.
|
650 |
2 |
4 |
|a Cancer Research.
|
650 |
2 |
4 |
|a Pathology.
|
650 |
2 |
4 |
|a Molecular Medicine.
|
650 |
2 |
4 |
|a Biotechnology.
|
700 |
1 |
|
|a Llombart-Bosch, Antonio.
|e editor.
|
700 |
1 |
|
|a López-Guerrero, José A.
|e editor.
|
700 |
1 |
|
|a Felipo, Vicente.
|e editor.
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer eBooks
|
856 |
4 |
0 |
|u https://doi.org/10.1007/978-1-4020-5133-3
|